My Portfolio
+
LINK YOUR PORTFOLIO

Vertex Pharmaceuticals Inc VRTX:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 5:34 PM EDT
431.20quote price arrow up+2.86 (+0.67%)
Volume
282,409
Close
428.34quote price arrow up+3.25 (+0.76%)
Volume
1,277,961
52 week range
362.50 - 507.92
Loading...
  • Open420.63
  • Day High429.01
  • Day Low420.01
  • Prev Close425.09
  • 52 Week High507.92
  • 52 Week High Date03/10/26
  • 52 Week Low362.50
  • 52 Week Low Date08/11/25

Latest On Vertex Pharmaceuticals Inc

 

Key Stats

  • Market Cap108.715B
  • Shares Out253.81M
  • 10 Day Average Volume1.37M
  • Dividend-
  • Dividend Yield-
  • Beta0.31

Latest On Vertex Pharmaceuticals Inc

 

KEY STATS

  • Open420.63
  • Day High429.01
  • Day Low420.01
  • Prev Close425.09
  • 52 Week High507.92
  • 52 Week High Date03/10/26
  • 52 Week Low362.50
  • 52 Week Low Date08/11/25
  • Market Cap108.715B
  • Shares Out253.81M
  • 10 Day Average Volume1.37M
  • Dividend-
  • Dividend Yield-
  • Beta0.31

RATIOS/PROFITABILITY

  • EPS (TTM)16.87
  • P/E (TTM)25.40
  • Fwd P/E (NTM)21.87
  • EBITDA (TTM)5.012B
  • ROE (TTM)24.20%
  • Revenue (TTM)12.218B
  • Gross Margin (TTM)86.24%
  • Net Margin (TTM)35.51%
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date08/03/2026(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Vertex Pharmaceuticals Incorporated is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious diseases, with a focus on specialty markets. It has seven approved medicines: five that treat the underlying cause of cystic fibrosis (CF), one that treats severe sickle cell disease (SCD) and transfusion dependent beta thalassemia (TDT), and one that treats moderate-to-severe acute pain. Its pipeline includes...
Jeffrey Leiden M.D., Ph.D.
Executive Chairman of the Board
Reshma Kewalramani M.D.
President, Chief Executive Officer, Director
Charles Wagner Jr.
Executive Vice President, Chief Operating and Financial Officer
E. Morrow Atkinson Ph.D.
Executive Vice President, Chief Technical Operations Officer, Head of Biopharmaceutical Science and Manufacturing Operations
Carmen Bozic M.D.
Executive Vice President - Global Medicines Development and Medical Affairs, Chief Medical Officer
Address
50 Northern Avenue
Boston, MA
02210
United States